Skip to content
OpenCapital
Get started

Integra LifeSciences IART Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
——

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%—
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%—
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's increase (decrease) in contract liabilities and current deferred income?
Integra LifeSciences (IART) reported increase (decrease) in contract liabilities and current deferred income of -$630K in Q1 2026.
How has Integra LifeSciences's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
Integra LifeSciences's increase (decrease) in contract liabilities and current deferred income decreased by 358.2% year-over-year, from $244K to -$630K.
What is the long-term trend for Integra LifeSciences's increase (decrease) in contract liabilities and current deferred income?
Over 3 years (2021 to 2025), Integra LifeSciences's increase (decrease) in contract liabilities and current deferred income has grown at a 395.2% compound annual growth rate (CAGR), from $28K to $3.4M.